Skip to main content

CORRECTION article

Front. Immunol., 21 September 2023
Sec. Molecular Innate Immunity
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1294153

Corrigendum: Complement activation via the lectin and alternative pathway in patients with severe COVID-19

This article is a correction to:

  1. Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19

    1. Read original article
Janina NiederreiterJanina Niederreiter1Christine EckChristine Eck1Tajana RiesTajana Ries1Arndt HartmannArndt Hartmann2Bruno MrklBruno Märkl3Maike Buettner-HeroldMaike Buettner-Herold1Kerstin AmannKerstin Amann1Christoph Daniel*Christoph Daniel1*
  • 1Department of Nephropathology, University Hospital Erlangen, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg, Erlangen, Germany
  • 2Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University (FAU) Erlangen-Nürnberg, Erlangen, Germany
  • 3General Pathology and Molecular Diagnostics, Medical Faculty Augsburg, University Augsburg, Augsburg, Germany

A Corrigendum on
Complement activation via the lectin and alternative pathway in patients with severe COVID-19

by Niederreiter J, Eck C, Ries T, Hartmann A, Märkl B, Büttner-Herold M, Amann K and Daniel C (2022) Front. Immunol. 13:835156. doi: 10.3389/fimmu.2022.835156

In the published article, information in the Acknowledgments was mistakenly not included in the publication. A correction has been made to Acknowledgments:

Acknowledgments

The present work was performed in (partial) fulfillment of the requirements for obtaining the degree ‘Dr. med.’ from the Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) for JN. The technical assistance of Stefan Söllner, Sina Dassler, Carolin Hamann, Iris Scheitacker and Miriam Reutelshöfer is gratefully acknowledged. The authors are thankful to Lukas Borcherding for compiling the cases from the Augsburg Autopsy Series.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: complement deposition, COVID-19, kidney, lung, autopsy, lectin pathway

Citation: Niederreiter J, Eck C, Ries T, Hartmann A, Märkl B, Buettner-Herold M, Amann K and Daniel C (2023) Corrigendum: Complement activation via the lectin and alternative pathway in patients with severe COVID-19. Front. Immunol. 14:1294153. doi: 10.3389/fimmu.2023.1294153

Received: 14 September 2023; Accepted: 15 September 2023;
Published: 21 September 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Niederreiter, Eck, Ries, Hartmann, Märkl, Buettner-Herold, Amann and Daniel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Christoph Daniel, Christoph.Daniel@uk-erlangen.de

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.